Concussion – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Concussion Market Outlook
Thelansis’s “Concussion Market
Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024
To 2034" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Concussion treatment modalities options for
eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
Concussion Overview
A
concussion results from a traumatic impact, causing temporary brain function
disturbance. It falls under traumatic brain injuries, which range from mild,
brief symptoms to prolonged altered consciousness. The injury can stem from
direct head impact or indirect forces affecting the brain due to body trauma.
Common Concussion Symptoms include Confusion, Headache, Vision issues
(blurriness, double vision), Dizziness or imbalance, Nausea or vomiting, Memory
lapses, and Ringing in the ears. The underlying mechanism of a concussion is
intricate, involving neurochemical and neurometabolic changes rather than just
physical damage. Axonal injury from head movement disrupts neurofilament
arrangement, releasing electrolytes and neurotransmitters that lead to neurologic
dysfunction. Metabolic shifts and reduced cerebral blood flow also contribute.
Concussion treatment focuses on support, beginning with reduced physical and
cognitive activity and gradual reintegration. Initial diagnosis should consider
severe possibilities like spinal injury, intracranial bleeding, or skull
fractures. Post-injury, the prognosis is favorable, with symptoms improving
within weeks. A complication is post-concussion syndrome (PCS), showing
prolonged symptoms. Annually, the USA sees over 300,000 sports-related
concussions, particularly prevalent in contact sports. The risk of experiencing
a concussion in contact sports can be as high as 19% per year. High school
contact sports alone report 62,000 concussions yearly. College football players
show 34% with one and 20% with multiple concussions. Estimates suggest that
4-20% of college and high school football players acquire brain injuries in a
single season, with a higher risk after a previous concussion.
Geography coverage:
G8 (United States, EU5 [France,
Germany, Italy, Spain, U.K.], Japan, and China)
Insights driven by robust
research, including:
- In-depth interviews with leading KOLs and payers
- Physician surveys
- RWE analysis for claims and EHR datasets
- Secondary research (e.g., peer-reviewed journal
articles, third-party research databases)
Deliverables format and
updates*:
- Detailed Report (PDF)
- Market Forecast Model (MS Excel-based automated
dashboard)
- Epidemiology (MS Excel; interactive tool)
- Executive Insights (PowerPoint presentation)
- Others: regular updates, customizations, consultant
support
*As per Thelansis’s policy, we
ensure that we include all the recent updates before releasing the report
content and market model.
Salient features of Market
Forecast model:
- 10-year market forecast (2024–2034)
- Bottom-up patient-based market forecasts validated
through the top-down sales methodology
- Covers clinically and commercially-relevant patient
populations/ line of therapies
- Annualized drug-level sales and patient share
projections
- Utilizes our proprietary Epilansis and Analog tool
(e.g., drug uptake and erosion) datasets and conjoint analysis approach
- Detailed methodology/sources & assumptions
- Graphical and tabular outputs
- Users can customize the model based on requirements
Key business questions answered:
- How can drug development and lifecycle management
strategies be optimized across G8 markets (US, EU5, Japan, and China)?
- How large is the patient population in terms of
incidence, prevalence, segments, and those receiving drug treatments?
- What is the 10-year market outlook for sales and
patient share?
- Which events will have the greatest impact on the
market’s trajectory?
- What insights do interviewed experts provide on
current and emerging treatments?
- Which pipeline products show the most promise, and
what is their potential for launch and future positioning?
- What are the key unmet needs and KOL expectations for
target profiles?
- What key regulatory and payer requirements must be
met to secure drug approval and favorable market access?
- and more…
Comments
Post a Comment